LP 164 LP 164 Pill - green & pink capsule/oblong, 22mm
Pill with imprint LP 164 LP 164 is Green & Pink, Capsule/Oblong and has been identified as Hydroxyurea 500 mg. It is supplied by Leading Pharma, LLC.
Hydroxyurea is used in the treatment of Chronic Myelogenous Leukemia; Sickle Cell Anemia; Head and Neck Cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydroxyurea 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LP 164 LP 164
Hydroxyurea
- Imprint
- LP 164 LP 164
- Strength
- 500 mg
- Color
- Green & Pink
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Leading Pharma, LLC
- National Drug Code (NDC)
- 69315-0164
More about hydroxyurea
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
- Hydroxyurea drug information
- Hydroxyurea Capsules 200 mg, 300 mg, 400 mg
- Hydroxyurea Tablets
- Hydroxyurea Capsules 500 mg
Other brands
Hydrea, Droxia, Siklos, Xromi, Mylocel
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.